Global Markets

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

RBI's May Review

RBI's May Review

Subbarao overrules panel view on rate action in May.  Full Article 

New Chief

New Chief

P&G brings back A.G. Lafley as CEO, McDonald out.  Full Article 

Bernanke Impact

Bernanke Impact

U.S. Fed enters delicate new phase of communication  Full Article | Column 

Ranbaxy Fine

Ranbaxy Fine

Daiichi Sankyo accusation "false and baseless": Singhs  Full Article 

Ad Sales' Scrutiny

Ad Sales' Scrutiny

Google faces new federal antitrust probe - source.  Full Article 

Tax Holiday

Tax Holiday

Apple enjoyed Irish tax holiday from the start.  Full Article 

FDA Woes

FDA Woes

Wockhardt says FDA alert affects potential sales of $100 million.  Full Article 

Goldman Safeguards

Goldman Safeguards

Goldman unveils checks on conflicts in bid to fix image.  Full Article 

Buy, Sell or Hold?

Buy, Sell or Hold?

Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade.  Full Coverage 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage 

TABLE-India's Maruti Suzuki Nov sales up 12.5 pct

Stocks

   

Sat Dec 1, 2012 4:37pm IST

Dec 1 (Reuters) - Maruti Suzuki India Ltd's 
vehicle sales in November:
                     Nov 2012     Nov 2011    pct chg
    TOTAL SALES           103,200      91,772       12.5  
    DOMESTIC SALES         90,882      82,870        9.7      
    PASSENGER CARS         74,793      73,078        2.3     
    EXPORTS                12,318       8,902       38.4       
       
    NOTE: Maruti Suzuki India, controlled by Japan's Suzuki
Motor Corp, is India's largest carmaker and also makes
commercial vehicles.  
    The carmaker suffered supply delays in September 2011 on
strikes at its Manesar plant that affected its sales volume in
October 2011.

 (Reporting by Suvashree Dey Choudhhury in MUMBAI; Editing by
Keiron Henderson)
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.